Literature DB >> 6202988

Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment.

D M Mann, P O Yates, B Marcyniuk.   

Abstract

The number of nerve cells in the nucleus basalis of Meynert in normally aged persons is reduced by 30% by 90 years of age and cytoplasmic RNA content and nucleolar volume by about 20%. In Alzheimer's disease the changes are greatly exacerbated, with the cell number being depleted by a further 60% and cytoplasmic RNA content and nucleolar volume by an extra 35%. Moreover, younger patients with Alzheimer's disease show a much greater difference from controls of the same age than do older patients; indeed, by 90 years of age the levels of these changes are similar in Alzheimer's disease and in old age alone. Lipofuscin content is increased to a similar extent with age in both Alzheimer's disease and control patients and was associated with loss of cytoplasmic RNA content and nucleolar volume in both groups. It is suggested that mechanisms which result in the accumulation of this pigment during life also lower the capability of cells of the nucleus basalis of Meynert to withstand disease pathogens, leading to a certain degree of change in old age alone and one which in other persons may be compounded by secondary factors giving the extreme degeneration of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202988     DOI: 10.1016/0047-6374(84)90140-4

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  23 in total

1.  Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease.

Authors:  Stefan Teipel; Helmut Heinsen; Edson Amaro; Lea T Grinberg; Bernd Krause; Michel Grothe
Journal:  Neurobiol Aging       Date:  2013-10-28       Impact factor: 4.673

2.  Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan J Teipel
Journal:  Biol Psychiatry       Date:  2011-08-04       Impact factor: 13.382

3.  Angioarchitectonics of the cerebral cortex and the blood-brain barrier in Alzheimer's disease.

Authors:  M L Orlova
Journal:  Neurosci Behav Physiol       Date:  1989 Nov-Dec

4.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Michel Grothe; Jose L Cantero; Maximilian F Reiser; Hans-Jürgen Möller; Helmut Heinsen; Harald Hampel
Journal:  Hum Brain Mapp       Date:  2010-07-29       Impact factor: 5.038

5.  MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia.

Authors:  Haruo Hanyu; Tetsuichi Asano; Hirofumi Sakurai; Yuriko Tanaka; Masaru Takasaki; Kimihiko Abe
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

6.  Bacterial melanin increases electrical activity of neurons in Substantia Nigra pars compacta.

Authors:  T R Petrosyan; V A Chavushyan; A S Hovsepyan
Journal:  J Neural Transm (Vienna)       Date:  2014       Impact factor: 3.575

7.  Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.

Authors:  Michel J Grothe; Michael Ewers; Bernd Krause; Helmut Heinsen; Stefan J Teipel
Journal:  Alzheimers Dement       Date:  2014-01-10       Impact factor: 21.566

8.  The nucleus basalis of Meynert in multi-infarct (vascular) dementia.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice.

Authors:  Jessica A Ash; Ramon Velazquez; Christy M Kelley; Brian E Powers; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Neurobiol Dis       Date:  2014-06-14       Impact factor: 5.996

10.  Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.

Authors:  Michel Grothe; Helmut Heinsen; Stefan Teipel
Journal:  Neurobiol Aging       Date:  2012-11-15       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.